AARD
Aardvark Therapeutics Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$5.09
-0.17 ▼ -3.23%
🌙 3월 13일 5:21 PM ET (한국 3/14 06:21)
$5.10
+0.01 ▲ +0.20%
| Index | RUT | P/E | - | EPS (ttm) | -2.25 | Insider Own | 44.76% | Shs Outstand | 0.02B | Perf Week | -12.99% |
| Market Cap | 0.11B | Forward P/E | - | EPS next Y | -29.42% | Insider Trans | 0.21% | Shs Float | 0.01B | Perf Month | -59.83% |
| Enterprise Value | -0.01B | PEG | - | EPS next Q | -0.83 | Inst Own | 29.28% | Short Float | 15.02% | Perf Quarter | -63.59% |
| Income | -0.05B | P/S | - | EPS this Y | 43.07% | Inst Trans | 11.34% | Short Ratio | 6.49 | Perf Half Y | -34.66% |
| Sales | 0.00B | P/B | 0.9 | EPS next 5Y | 12.8% | ROA | -44.96% | Short Interest | 1.81M | Perf YTD | -61.22% |
| Book/sh | 5.63 | P/C | 0.88 | EPS past 3/5Y | -22.31% - | ROE | -48.06% | 52W High | -71.63% ($17.94) | Perf Year | -51.43% |
| Cash/sh | 5.8 | P/FCF | - | Sales past 3/5Y | - | ROIC | -39.82% | 52W Low | 7.38% ($4.74) | Perf 3Y | - |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 31.3% | Gross Margin | - | Volatility(W/M) | 11.29% 8.11% | Perf 5Y | - |
| Dividend TTM | - | EV/Sales | - | Sales Y/Y TTM | - | Oper. Margin | - | ATR (14) | 0.93 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 12.03 | EPS Q/Q | -283.59% | Profit Margin | - | RSI (14) | 23.21 | Recom | 1.67 |
| Dividend Gr. 3/5Y | - | Current Ratio | 12.03 | Sales Q/Q | - | SMA20 | -43.32% ($8.98) | Beta | 4.69 | Target Price | $22.55 |
| Payout | - | Debt/Eq | 0 | Earnings | 11000000 | SMA50 | -57.24% ($11.9) | Rel Volume | 0.96 | Prev Close | $5.26 |
| Employees | 22 | LT Debt/Eq | 0 | EPS/Sales Surpr. | 6.09% - | SMA200 | -57.2% ($11.89) | Avg Volume(3M) | 0.28M | Price | $5.09 |
| IPO | 2025/2/13 | Option/Short | Yes/Yes | Trades | 2494 | Volume | 266,370 | Change | -3.23% |
뉴스 로딩 중...